The National Radium-223 Dichloride Audit group: Data from patients in UK oncology centers with metastatic castration-resistant prostate cancer treated with radium-223 dichloride.

被引：0
|
作者：
Randhawa, Manreet
Jones, Robert J.
Stratton, Irene
机构：
[1] Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland
[2] Univ Glasgow, Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland
[3] Gloucestershire Retinal Res Grp, Cheltenham, Glos, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e16524
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16524
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Radium-223 dichloride for the treatment of castration-resistant prostate cancer with symptomatic bone metastases
    Vogelzang, Nicholas J.
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (08) : 809 - 819
  • [12] Nursing Management of Patients With Castration-Resistant Prostate Cancer Undergoing Radium-223 Dichloride Treatment
    Delacruz, Anthony
    Arauz, Gabrielle
    Curley, Tracy
    Lindo, Amabella
    Jensen, Trine
    [J]. CLINICAL JOURNAL OF ONCOLOGY NURSING, 2015, 19 (02) : E31 - E35
  • [13] A Phase lb Study of Atezolizumab with Radium-223 Dichloride in Men with Metastatic Castration-Resistant Prostate Cancer
    Fong, Lawrence
    Morris, Michael J.
    Sartor, Oliver
    Higano, Celestia S.
    Pagliaro, Lance
    Alva, Ajjai
    Appleman, Leonard J.
    Tan, Winston
    Vaishampayan, Ulka
    Porcu, Raphaelle
    Tayama, Darren
    Kadel, Edward E., III
    Yuen, Kobe C.
    Datye, Asim
    Armstrong, Andrew J.
    Petrylak, Daniel P.
    [J]. CLINICAL CANCER RESEARCH, 2021, 27 (17) : 4746 - 4756
  • [14] Radium-223 dichloride for the treatment of bone metastatic castration-resistant prostate cancer: an evaluation of its safety
    Nilsson, Sten
    [J]. EXPERT OPINION ON DRUG SAFETY, 2015, 14 (07) : 1127 - 1136
  • [15] RADIUM-223: TREATING METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
    James, D.
    Hillery, R.
    Freeman, L.
    Kumari, A.
    Kearney, N.
    [J]. INTERNAL MEDICINE JOURNAL, 2016, 46 : 30 - 31
  • [16] Radium-223 In The Treatment Of Metastatic Castration-Resistant Prostate Cancer
    Vazzana, C.
    Morano, S.
    Di Lascio, A.
    Grana, C.
    Chinol, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S880 - S880
  • [17] Radium-223 in metastatic castration resistant prostate cancer
    Vuong, Winston
    Sartor, Oliver
    Pal, Sumanta K.
    [J]. ASIAN JOURNAL OF ANDROLOGY, 2014, 16 (03) : 348 - 353
  • [18] Real-world outcomes of radium-223 dichloride for metastatic castration resistant prostate cancer
    Kuppen, Malou C. P.
    Westgeest, Hans M.
    van der Doelen, Maarten J.
    van den Eertwegh, Alphonsus J. M.
    Coenen, Jules L. L. M.
    Aben, Katja K. H.
    van den Bergh, Alphons C. M.
    Bergman, Andries M.
    van den Bosch, Joan
    Celik, Filiz
    Hendriks, Mathijs P.
    Lavalaye, Jules
    van der Meer, Saskia
    Polee, Marco B.
    Somford, Diederik M.
    van Oort, Inge M.
    Uyl-de Groot, Carin A.
    Gerritsen, Winald R.
    [J]. FUTURE ONCOLOGY, 2020, 16 (19) : 1371 - 1384
  • [19] RADIUM-223 DICHLORIDE (RADIUM-223) FOR THE TREATMENT OF PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER AND SYMPTOMATIC BONE METASTASES: THE ESSENTIAL ROLE OF NURSES IN PATIENT CARE AND MANAGEMENT
    Curley, Tracy
    Arauz, Gabrielle
    Jensen, Trine
    Wahba, Mona
    Delacruz, Anthony
    [J]. ONCOLOGY NURSING FORUM, 2014, 41 (02) : E115 - E115
  • [20] Efficacy and Safety of Radium-223 Dichloride in the Treatment of Patients with Castration-Resistant Prostate Cancer with Bone Metastases
    Sanchez Lopez, Hector
    [J]. GACETA MEXICANA DE ONCOLOGIA, 2016, 15 : 1 - 2
12345